Related Experiment Video

Updated: Aug 14, 2026

The Use of a β-lactamase-based Conductimetric Biosensor Assay to Detect Biomolecular Interactions
08:06

The Use of a β-lactamase-based Conductimetric Biosensor Assay to Detect Biomolecular Interactions

Published on: February 1, 2018

[Increased bleeding tendency induced by beta-lactam antibiotics]

Martin T Mellerup1, Niels Eske Bruun, Jørn Dalsgaard Nielsen

  • 1Klinisk-Biokemisk Afdeling, Amtssygehuset i Gentofte, Københavns Amts Trombosecenter. mame@gentoftehosp.kbhamt.dk

Ugeskrift for Laeger
|July 15, 2005
PubMed

Insights

Beta-lactam antibiotics can cause bleeding, a rare side effect noted since 1970. This study reports three new cases of bleeding in patients receiving high-dose penicillin for severe infections.

Area of Science:

  • Pharmacology
  • Hematology

Background:

  • Bleeding complications associated with beta-lactam antibiotics have been documented since 1970.
  • Despite documented cases, no universal screening or treatment guidelines exist for this adverse effect.

Observation:

  • Three cases of presumed beta-lactam-induced bleeding were observed over seven months.
  • Patients presented with severe infections, including endocarditis and septic shock.
  • Treatment involved high-dose penicillin, a common beta-lactam antibiotic.

Findings:

  • High-dose penicillin therapy was linked to significant bleeding events in these patients.
  • The observed bleeding episodes suggest a potential risk in critically ill patients.
  • Further investigation into the mechanism and frequency of this adverse drug reaction is warranted.

Implications:

  • Clinicians should maintain awareness of potential bleeding risks with beta-lactam antibiotics, especially in high-risk patients.
  • Consideration of bleeding as an adverse effect may be necessary in patients on prolonged or high-dose beta-lactam therapy.
  • This highlights the need for updated clinical guidelines regarding beta-lactam-associated bleeding.

More Related Videos

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

Lipopolysaccharide Infusion as a Porcine Endotoxemic Shock Model05:52

Lipopolysaccharide Infusion as a Porcine Endotoxemic Shock Model

Published on: December 8, 2023

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration01:23

Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration

Drug elimination from the body primarily occurs through metabolic and excretion pathways. Hepatic metabolism transforms lipophilic drugs into hydrophilic forms for excretion, typically via enzymatic processes classified as phase I (modification) and phase II (conjugation). Renal excretion eliminates drugs and metabolites through filtration and secretion in the kidneys. Impairment in liver or kidney function can hinder these processes, delaying drug clearance and extending the drug’s half-life.
Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...